litlas
ログインアカウント作成

Jörge E. Cortes

1991–2025 年に発表

別表記
Jorge E. Cortes
618
論文数
112,108
被引用数
179
h 指数
596
i10 指数

被引用数

Jörge E. Cortes の年別被引用数1975 年: 被引用 1 件1979 年: 被引用 12 件1984 年: 被引用 1 件1992 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 2 件1997 年: 被引用 8 件1998 年: 被引用 10 件1999 年: 被引用 20 件2000 年: 被引用 31 件2001 年: 被引用 52 件2002 年: 被引用 134 件2003 年: 被引用 285 件2004 年: 被引用 326 件2005 年: 被引用 306 件2006 年: 被引用 489 件2007 年: 被引用 678 件2008 年: 被引用 699 件2009 年: 被引用 816 件2010 年: 被引用 845 件2011 年: 被引用 807 件2012 年: 被引用 841 件2013 年: 被引用 870 件2014 年: 被引用 834 件2015 年: 被引用 927 件2016 年: 被引用 961 件2017 年: 被引用 852 件2018 年: 被引用 875 件2019 年: 被引用 3,220 件2020 年: 被引用 3,658 件2021 年: 被引用 3,431 件2022 年: 被引用 2,605 件2023 年: 被引用 1,984 件2024 年: 被引用 3,379 件2025 年: 被引用 1,401 件2026 年: 被引用 19 件1976〜1978 年は被引用が無いため表示していません1980〜1983 年は被引用が無いため表示していません1985〜1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,515 件、この内訳の 29.6%中国: 引用元論文 2,100 件、この内訳の 8.3%ドイツ: 引用元論文 1,776 件、この内訳の 7%イタリア: 引用元論文 1,616 件、この内訳の 6.3%イギリス: 引用元論文 1,491 件、この内訳の 5.9%フランス: 引用元論文 1,246 件、この内訳の 4.9%スペイン: 引用元論文 786 件、この内訳の 3.1%カナダ: 引用元論文 764 件、この内訳の 3%オーストラリア: 引用元論文 664 件、この内訳の 2.6%スイス: 引用元論文 579 件、この内訳の 2.3%オランダ: 引用元論文 567 件、この内訳の 2.2%日本: 引用元論文 564 件、この内訳の 2.2%
0%29.6%その他 22.6%

機関

分野

  • Medicine71.9%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Immunology and Microbiology3.3%
  • Materials Science0.9%
  • Computer Science0.8%
  • Chemistry0.7%
  • その他1.9%

トピック

  • Acute Myeloid Leukemia Research11.1%
  • Chronic Myeloid Leukemia Treatments7.9%
  • Chronic Lymphocytic Leukemia Research4.7%
  • Acute Lymphoblastic Leukemia research4.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.1%
  • Eosinophilic Disorders and Syndromes3.1%
  • その他64.7%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML

    著者: Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R. Baer, Richard A. Larson, Celalettin Üstün, Francesco Fabbiano, Harry P. Erba, Antonio Di Stasi, Robert K. Stuart, Rebecca L. Olin, Margaret Kasner, Fabio Ciceri, Wen‐Chien Chou, Nikolai A. Podoltsev, Christian Récher, Hisayuki Yokoyama, Naoko Hosono, Sung‐Soo Yoon, Je‐Hwan Lee, Timothy S. Pardee, Amir T. Fathi, Chaofeng Liu, Nahla Hasabou, Xuan Liu, Erkut Bahceci, Mark J. Levis - New England Journal of Medicine 2019 被引用: 1,239

  3. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Harry P. Erba, Pau Montesinos, Hee‐Je Kim, Elżbieta Patkowska, Radovan Vrḫovac, Pavel Žák, Po‐Nan Wang, Tsvetomir Mitov, James Hanyok, Yasser Mostafa Kamel, Jaime E Connolly Rohrbach, Li Liu, Aziz Benzohra, Arnaud Lesegretain, Jörge E. Cortes, Alexander E. Perl, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Mark J. Levis, Richard F. Schlenk - The Lancet 2023 被引用: 366

  4. CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

    著者: Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Richard M. Stone, Dale L. Bixby, Jonathan E. Kolitz, Gary J. Schiller, Matthew J. Wieduwilt, Daniel H. Ryan, Antje Hoering, Kamalika Banerjee, Michael Chiarella, Arthur C. Louie, Bruno C. Medeiros - Journal of Clinical Oncology 2018 被引用: 990

  5. A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

    著者: Delphine Réa, Michael J. Mauro, Carla Boquimpani, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong‐Wook Kim, Jane F. Apperley, André Abdo, Laura Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saußele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Koji Sasaki, Lynette Chee, Valentín García‐Gutiérrez, Jörge E. Cortes, Paola Aimone, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Andreas Hochhaus - Blood 2021 被引用: 336

  6. Acute myeloid leukaemia

    著者: Nicholas J. Short, Michael Rytting, Jörge E. Cortes - The Lancet 2018 被引用: 781

  7. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

    著者: Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez, Jörge E. Cortes, Marina Konopleva, Farhad Ravandi‐Kashani, Elias Jabbour, Tapan M. Kadia, Graciela M. Nogueras‐González, Jing Ning, Naveen Pemmaraju, Courtney D. DiNardo, Michael Andreeff, Sherry Pierce, Tauna Gordon, Steven M. Kornblau, Wilmer Flores, Zainab Alhamal, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Keyur P. Patel, Jorge Blando, James P. Allison, Padmanee Sharma, Hagop M. Kantarjian - Cancer Discovery 2018 被引用: 571

  8. Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

    著者: Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes, Hironobu Minami, Delphine Réa, Daniel J. DeAngelo, Massimo Breccia, Yeow-Tee Goh, Moshe Talpaz, Andreas Hochhaus, Philipp le Coutre, Oliver G. Ottmann, Michael C. Heinrich, Juan Luis Steegmann, Michael W. Deininger, Jeroen J. W. M. Janssen, François-Xavier Mahon, Yosuke Minami, David T Yeung, David M. Ross, Martin S. Tallman, Jae H. Park, Brian Druker, David Hynds, Yuyan Duan, Christophe Meille, Florence Hourcade‐Potelleret, K. Gary J. Vanasse, Fabian Lang, Dong‐Wook Kim - New England Journal of Medicine 2019 被引用: 467

  9. A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    著者: Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Siu‐Fun Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, John M. Goldman, Neil P. Shah, Hagop M. Kantarjian - New England Journal of Medicine 2013 被引用: 1,124

  10. Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    著者: Rongqing Pan, Leah J. Hogdal, Juliana M. Benito, Donna Bucci, Lina Han, Gautam Borthakur, Jörge E. Cortes, Daniel J. DeAngelo, LaKeisha Debose, Hong Mu, Hartmut Döhner, Verena I. Gaidzik, Ilene Galinsky, Leonard S. Golfman, Torsten Haferlach, Karine G. Harutyunyan, Jianhua Hu, Joel D. Leverson, Guido Marcucci, Markus Müschen, Rachel Newman, Eugene Park, Peter P. Ruvolo, Vivian Ruvolo, Jeremy Ryan, Sonja Schindela, Patrick A. Zweidler‐McKay, Richard M. Stone, Hagop M. Kantarjian, Michael Andreeff, Marina Konopleva, Anthony Letai - Cancer Discovery 2013 被引用: 735

  11. Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

    著者: Jörge E. Cortes, Dong‐Wook Kim, Javier Pinilla‐Ibarz, Philipp D. le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Stephanie Lustgarten, Victor M. Rivera, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, Neil P. Shah, Hagop M. Kantarjian - Blood 2018 被引用: 583

  12. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

    著者: Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A. Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika J. Thompson, Keyur P. Patel, Carlos E. Bueso‐Ramos, Courtney D. DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jörge E. Cortes, Kapil N. Bhalla, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Marina Konopleva, Daisuke Nakada, Nicholas E. Navin, Niko Beerenwinkel, P. Andrew Futreal, Koichi Takahashi - Nature Communications 2020 被引用: 387

  13. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

    著者: Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian, Michele Baccarani, Jiřı́ Mayer, Concepción Boqué, Neil P. Shah, Charles Chuah, Luís Casanova, Brigid Bradley-Garelik, George Manos, Andreas Hochhaus - Journal of Clinical Oncology 2016 被引用: 946

  14. Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL

    著者: Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jörge E. Cortes, Timothy P. Hughes, Jane F. Apperley, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong‐Wook Kim, André Abdo, Laura Fogliatto, Philipp le Coutre, Koji Sasaki, Dennis Dong Hwan Kim, Susanne Saußele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, Valentín García‐Gutiérrez, S. S. Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J. Mauro - Leukemia 2023 被引用: 135

  15. Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML

    著者: Stéphane de Botton, Pierre Fenaux, Karen Yee, Christian Récher, Andrew H. Wei, Pau Montesinos, David Taussig, Arnaud Pigneux, Thorsten Braun, Antonio Curti, Carolyn Grove, Brian A. Jonas, Asim Khwaja, Ollivier Legrand, Pierre Péterlin, Montserrat Arnán, William Blum, Daniela Cilloni, Devendra Hiwase, Joseph G. Jurcic, Jürgen Krauter, Xavier Thomas, Justin M. Watts, Jay Yang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Emma Barrett, Jörge E. Cortes - Blood Advances 2023 被引用: 124

  16. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

    著者: Animesh Pardanani, Claire Harrison, Jörge E. Cortes, Francisco Cervantes, Ruben A. Mesa, Donald Milligan, Tamás Masszi, Elena Mishchenko, Éric Jourdan, Alessandro M. Vannucchi, Mark W. Drummond, Mindaugas Jurgutis, Kazimierz Kuliczkowski, Emanuil Gheorghita, Francesco Passamonti, Frank Neumann, Abhay Patki, Guozhi Gao, Ayalew Tefferi - JAMA Oncology 2015 被引用: 472

  17. Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

    著者: Jörge E. Cortes, Carlo Gambacorti‐Passerini, Michael W. Deininger, Michael J. Mauro, Charles Chuah, Dong‐Wook Kim, Iryna Dyagil, Nataliia Glushko, Dragana Milojković, Philipp le Coutre, Valentín García‐Gutiérrez, Laurence Reilly, Allison Jeynes-Ellis, Eric Leip, Nathalie Bardy‐Bouxin, Andreas Hochhaus, Tim H. Brümmendorf - Journal of Clinical Oncology 2017 被引用: 493

  18. Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

    著者: Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli, Alexander E. Perl, Siddhartha Ganguly, Nigel H. Russell, Alwin Krämer, Hervé Dombret, Donna E. Hogge, Brian A. Jonas, Anskar Y.H. Leung, Priyanka Mehta, Pau Montesinos, Markus P. Radsak, Simona Sica, Meena Arunachalam, Melissa F. Holmes, Ken Kobayashi, Ruth Namuyinga, Nanxiang Ge, Antoine Yver, Yufen Zhang, Mark J. Levis - The Lancet Oncology 2019 被引用: 479

  19. Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

    著者: Jörge E. Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Arthur, Lori J. Maness, Moshe Talpaz, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael Deininger - Blood 2021 被引用: 193

  20. The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

    著者: Patrick Williams, Sreyashi Basu, Guillermo Garcia‐Manero, Christopher S. Hourigan, Karolyn A. Oetjen, Jörge E. Cortes, Farhad Ravandi, Elias Jabbour, Zainab Alhamal, Marina Konopleva, Jing Ning, Lianchun Xiao, Juliana Hidalgo Lopez, Steve Kornblau, Michael Andreeff, Wilmer Flores, Carlos E. Bueso‐Ramos, Jorge Blando, Pallavi Galera, Katherine R. Calvo, Gheath Alatrash, James P. Allison, Hagop M. Kantarjian, Padmanee Sharma, Naval Daver - Cancer 2018 被引用: 341

  21. Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

    著者: Justin M. Watts, Maria R. Baer, Jay Yang, Thomas Prébet, Sang‐Min Lee, Gary J. Schiller, Shira Dinner, Arnaud Pigneux, Pau Montesinos, Eunice S. Wang, Karen Seiter, Andrew H. Wei, Stéphane de Botton, Montserrat Arnán, Will Donnellan, Anthony P. Schwarer, Christian Récher, Brian A. Jonas, P. Brent Ferrell, Christophe Marzac, Patrick Kelly, Jennifer Sweeney, Sanjeev Forsyth, Sylvie M. Guichard, Julie Brevard, Patrick Henrick, Hesham Mohamed, Jörge E. Cortes - The Lancet Haematology 2022 被引用: 117

  22. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

    著者: Jeffrey E. Lancet, Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Dale L. Bixby, Jonathan E. Kolitz, Gary J. Schiller, Matthew J. Wieduwilt, Daniel Ryan, Stefan Faderl, Jörge E. Cortes - The Lancet Haematology 2021 被引用: 211

  23. Mutations in AML: prognostic and therapeutic implications

    著者: Courtney D. DiNardo, Jörge E. Cortes - Hematology 2016 被引用: 265

  24. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

    著者: Abhishek Maiti, Caitlin R. Rausch, Jörge E. Cortes, Naveen Pemmaraju, Naval Daver, Farhad Ravandi, Guillermo Garcia‐Manero, Gautam Borthakur, Kiran Naqvi, Maro Ohanian, Nicholas J. Short, Yesid Alvarado, Tapan M. Kadia, Koichi Takahashi, Musa Yılmaz, Nitin Jain, Steven M. Kornblau, Guillermo Montalban‐Bravo, Koji Sasaki, Michael Andreeff, Prithiviraj Bose, Alessandra Ferrajoli, Ghayas C. Issa, Elias Jabbour, Lucia Masárová, Philip A. Thompson, Sa Wang, Sergej Konoplev, Sherry Pierce, Jing Ning, Wei Qiao, John S. Welch, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Konopleva - Haematologica 2020 被引用: 173